| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 0.957 | 5 | 0 | 1999 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.967 | 5 | 0 | 1993 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.390 | None | 1.000 | 4 | 0 | 2006 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 4 | 0 | 1985 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.400 | None | 0.972 | 4 | 0 | 1977 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.989 | 4 | 0 | 1988 | 2020 | ||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.350 | None | 1.000 | 3 | 0 | 2006 | 2017 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 1992 | 2019 | ||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.977 | 3 | 0 | 2001 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.400 | None | 0.978 | 3 | 0 | 2001 | 2019 | |||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 0.972 | 2 | 0 | 1997 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 2 | 0 | 1989 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.400 | None | 0.923 | 2 | 0 | 1997 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2020 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
disease | 0.600 | None | 0.941 | 2 | 0 | 2002 | 2020 | ||||||||
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.923 | 2 | 0 | 2011 | 2018 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.980 | 2 | 0 | 1995 | 2019 | ||||||||
|
solute carrier family 22 member 10 | 0.769 | 0.308 | 1.9E-19 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
heat shock protein family A (Hsp70) member 5 | 0.434 | 0.885 | 0.77 |
|
disease | 0.400 | None | 0.974 | 2 | 0 | 2001 | 2020 |